From #ADA2026 - The triple hormone receptor agonist #retatrutide significantly improves glycemic control and bodyweight in people with early #Type2Diabetes.
šļø buff.ly/GyG7Sds
#T2D
The triple hormone receptor agonist retatrutide significantly improves glycemic control and bodyweight in people with early type 2 diabetes.